Literature DB >> 7319134

Sublingual buprenorphine versus oral dihydrocodeine in post-operative pain.

A H Masson.   

Abstract

The effect of sublingual buprenorphine (0.4 mg) was compared with that of oral dihydrocodeine (60 mg) in patients experiencing post-operative pain following general surgery. Pain relief was significantly greater for buprenorphine than for dihydrocodeine, based on both peak effect and total effect. Both treatments were effective from 30 minutes. There was evidence that buprenorphine and a slightly slower onset of action, but a distinctly longer duration of action, than dihydrocodeine. Unwanted effects were similar for both treatments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7319134     DOI: 10.1177/030006058100900614

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

Review 1.  Single dose dihydrocodeine for acute postoperative pain.

Authors:  J E Edwards; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.

Authors:  Laura Sheard; Clive E Adams; Nat M J Wright; Hany El-Sayeh; Richard Dalton; Charlotte N E Tompkins
Journal:  Trials       Date:  2007-01-08       Impact factor: 2.279

3.  Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.

Authors:  Nat M J Wright; Laura Sheard; Charlotte N E Tompkins; Clive E Adams; Victoria L Allgar; Nicola S Oldham
Journal:  BMC Fam Pract       Date:  2007-01-08       Impact factor: 2.497

Review 4.  Benefit-Risk Analysis of Buprenorphine for Pain Management.

Authors:  Martin Hale; Mark Garofoli; Robert B Raffa
Journal:  J Pain Res       Date:  2021-05-24       Impact factor: 3.133

5.  The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].

Authors:  Nicola S Oldham; Nat M J Wright; Clive E Adams; Laura Sheard; Charlotte N E Tompkins
Journal:  BMC Fam Pract       Date:  2004-04-29       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.